Integer Holdings Corporation (ITGR)
USD 131.5
(-3.79%)
USD 131.5
(-3.79%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 250.95 Million USD | 13.3% |
| 2022 | 221.49 Million USD | 10.06% |
| 2021 | 201.25 Million USD | 21.9% |
| 2020 | 165.09 Million USD | -16.35% |
| 2019 | 197.37 Million USD | -4.7% |
| 2018 | 207.11 Million USD | -18.5% |
| 2017 | 254.11 Million USD | -5.89% |
| 2016 | 270.02 Million USD | 21.64% |
| 2015 | 221.98 Million USD | 42.53% |
| 2014 | 155.74 Million USD | -1.41% |
| 2013 | 157.97 Million USD | -10.15% |
| 2012 | 175.82 Million USD | 48.19% |
| 2011 | 118.65 Million USD | 4.0% |
| 2010 | 114.08 Million USD | -23.66% |
| 2009 | 149.45 Million USD | 25.95% |
| 2008 | 118.65 Million USD | 48.48% |
| 2007 | 79.91 Million USD | 15.68% |
| 2006 | 69.08 Million USD | -4.93% |
| 2005 | 72.66 Million USD | 35.12% |
| 2004 | 53.78 Million USD | 4.17% |
| 2003 | 51.62 Million USD | 16.72% |
| 2002 | 44.23 Million USD | 14.97% |
| 2001 | 38.47 Million USD | 11.77% |
| 2000 | 34.42 Million USD | 33.79% |
| 1999 | 25.72 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 53.77 Million USD | -19.43% |
| 2024 Q2 | 51.83 Million USD | -3.62% |
| 2024 Q3 | 55.83 Million USD | 12.98% |
| 2023 Q3 | 56.66 Million USD | -9.63% |
| 2023 FY | 250.95 Million USD | 13.3% |
| 2023 Q4 | 66.74 Million USD | 17.78% |
| 2023 Q1 | 60.97 Million USD | 11.12% |
| 2023 Q2 | 62.71 Million USD | 2.84% |
| 2022 Q1 | 55.93 Million USD | 5.14% |
| 2022 FY | 221.49 Million USD | 10.06% |
| 2022 Q4 | 54.87 Million USD | -0.12% |
| 2022 Q3 | 54.94 Million USD | -3.37% |
| 2022 Q2 | 56.86 Million USD | 1.65% |
| 2021 FY | 201.25 Million USD | 21.9% |
| 2021 Q3 | 46.87 Million USD | -4.69% |
| 2021 Q4 | 53.2 Million USD | 13.5% |
| 2021 Q1 | 49.14 Million USD | 7.73% |
| 2021 Q2 | 49.17 Million USD | 0.08% |
| 2020 Q4 | 45.61 Million USD | 165.61% |
| 2020 Q2 | 48.67 Million USD | -7.5% |
| 2020 Q1 | 52.62 Million USD | -1.42% |
| 2020 FY | 165.09 Million USD | -16.35% |
| 2020 Q3 | 17.17 Million USD | -64.72% |
| 2019 Q1 | 49.44 Million USD | 1.42% |
| 2019 Q4 | 53.38 Million USD | 19.52% |
| 2019 Q2 | 44.53 Million USD | -9.91% |
| 2019 Q3 | 44.66 Million USD | 0.28% |
| 2019 FY | 197.37 Million USD | -4.7% |
| 2018 FY | 207.11 Million USD | -18.5% |
| 2018 Q4 | 48.75 Million USD | 5.23% |
| 2018 Q3 | 46.32 Million USD | -14.85% |
| 2018 Q2 | 54.4 Million USD | -2.45% |
| 2018 Q1 | 55.77 Million USD | -20.65% |
| 2017 Q2 | 59.53 Million USD | 12.52% |
| 2017 Q3 | 59.6 Million USD | 0.12% |
| 2017 Q4 | 70.29 Million USD | 17.94% |
| 2017 FY | 254.11 Million USD | -5.89% |
| 2017 Q1 | 52.91 Million USD | -14.5% |
| 2016 FY | 270.02 Million USD | 21.64% |
| 2016 Q1 | 80.33 Million USD | -3.92% |
| 2016 Q2 | 66.76 Million USD | -16.89% |
| 2016 Q3 | 61.04 Million USD | -8.56% |
| 2016 Q4 | 61.88 Million USD | 1.37% |
| 2015 Q3 | 50.45 Million USD | 12.32% |
| 2015 Q1 | 43 Million USD | 8.05% |
| 2015 Q4 | 83.61 Million USD | 65.73% |
| 2015 FY | 221.98 Million USD | 42.53% |
| 2015 Q2 | 44.91 Million USD | 4.44% |
| 2014 Q3 | 41.93 Million USD | 7.72% |
| 2014 Q2 | 38.93 Million USD | 11.0% |
| 2014 Q1 | 35.07 Million USD | -21.23% |
| 2014 FY | 155.74 Million USD | -1.41% |
| 2014 Q4 | 39.8 Million USD | -5.08% |
| 2013 Q3 | 38.87 Million USD | -3.22% |
| 2013 FY | 157.97 Million USD | -10.15% |
| 2013 Q4 | 44.52 Million USD | 14.53% |
| 2013 Q2 | 40.16 Million USD | 16.73% |
| 2013 Q1 | 34.41 Million USD | -31.82% |
| 2012 Q3 | 48.82 Million USD | 19.55% |
| 2012 FY | 175.82 Million USD | 48.19% |
| 2012 Q2 | 40.84 Million USD | 14.44% |
| 2012 Q1 | 35.69 Million USD | 11.08% |
| 2012 Q4 | 50.46 Million USD | 3.36% |
| 2011 Q3 | 29.01 Million USD | 2.54% |
| 2011 FY | 118.65 Million USD | 4.0% |
| 2011 Q4 | 32.13 Million USD | 10.72% |
| 2011 Q2 | 28.3 Million USD | -3.09% |
| 2011 Q1 | 29.2 Million USD | -0.84% |
| 2010 FY | 114.08 Million USD | -23.66% |
| 2010 Q2 | 28.14 Million USD | 1.71% |
| 2010 Q1 | 27.66 Million USD | 526.45% |
| 2010 Q4 | 29.45 Million USD | 2.18% |
| 2010 Q3 | 28.82 Million USD | 2.43% |
| 2009 Q3 | 63.07 Million USD | 117.46% |
| 2009 FY | 149.45 Million USD | 25.95% |
| 2009 Q4 | -6.48 Million USD | -110.29% |
| 2009 Q2 | 29 Million USD | -1.23% |
| 2009 Q1 | 29.36 Million USD | -15.55% |
| 2008 Q4 | 34.77 Million USD | 33.55% |
| 2008 Q3 | 26.03 Million USD | -10.96% |
| 2008 Q2 | 29.24 Million USD | 2.25% |
| 2008 Q1 | 28.59 Million USD | 35.35% |
| 2008 FY | 118.65 Million USD | 48.48% |
| 2007 Q1 | 18.01 Million USD | 6.98% |
| 2007 Q2 | 19.7 Million USD | 9.36% |
| 2007 Q3 | 21.06 Million USD | 6.88% |
| 2007 Q4 | 21.13 Million USD | 0.33% |
| 2007 FY | 79.91 Million USD | 15.68% |
| 2006 FY | 69.08 Million USD | -4.93% |
| 2006 Q4 | 16.84 Million USD | -15.52% |
| 2006 Q3 | 19.93 Million USD | -3.26% |
| 2006 Q1 | 18.54 Million USD | 1.27% |
| 2006 Q2 | 20.6 Million USD | 11.15% |
| 2005 FY | 72.66 Million USD | 35.12% |
| 2005 Q4 | 18.3 Million USD | -19.53% |
| 2005 Q3 | 22.75 Million USD | 33.07% |
| 2005 Q2 | 17.09 Million USD | 17.8% |
| 2005 Q1 | 14.51 Million USD | 17.22% |
| 2004 FY | 53.78 Million USD | 4.17% |
| 2004 Q3 | 12.48 Million USD | -22.48% |
| 2004 Q4 | 12.38 Million USD | -0.86% |
| 2004 Q2 | 16.11 Million USD | 25.84% |
| 2004 Q1 | 12.8 Million USD | -0.33% |
| 2003 Q1 | 13.06 Million USD | 10.0% |
| 2003 FY | 51.62 Million USD | 16.72% |
| 2003 Q4 | 12.84 Million USD | 6.23% |
| 2003 Q3 | 12.09 Million USD | -11.25% |
| 2003 Q2 | 13.62 Million USD | 4.28% |
| 2002 Q2 | 9.63 Million USD | -5.55% |
| 2002 Q1 | 10.19 Million USD | 0.43% |
| 2002 FY | 44.23 Million USD | 14.97% |
| 2002 Q4 | 11.87 Million USD | -5.2% |
| 2002 Q3 | 12.53 Million USD | 30.11% |
| 2001 Q1 | 8.6 Million USD | -4.9% |
| 2001 FY | 38.47 Million USD | 11.77% |
| 2001 Q2 | 9.61 Million USD | 11.72% |
| 2001 Q3 | 10.1 Million USD | 5.04% |
| 2001 Q4 | 10.15 Million USD | 0.5% |
| 2000 Q3 | 7.14 Million USD | 0.0% |
| 2000 Q4 | 9.05 Million USD | 26.66% |
| 2000 FY | 34.42 Million USD | 33.79% |
| 1999 FY | 25.72 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 98.403% |
| Allurion Technologies Inc. | 120.57 Million USD | -108.135% |
| Artivion, Inc. | 223.43 Million USD | -12.319% |
| Avanos Medical, Inc. | 375.5 Million USD | 33.167% |
| Butterfly Network, Inc. | 162.46 Million USD | -54.469% |
| Butterfly Network, Inc. | 162.46 Million USD | -54.469% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 76.043% |
| Boston Scientific Corporation | 7.47 Billion USD | 96.644% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -1340.141% |
| CONMED Corporation | 564.24 Million USD | 55.523% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | 91.881% |
| Paragon 28, Inc. | 210.1 Million USD | -19.447% |
| Glaukos Corporation | 367.83 Million USD | 31.774% |
| Globus Medical, Inc. | 887.16 Million USD | 71.712% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | 55.855% |
| Medtronic plc | 16.12 Billion USD | 98.444% |
| Nevro Corp. | 389.36 Million USD | 35.547% |
| Owlet, Inc. | 51.21 Million USD | -389.972% |
| Penumbra, Inc. | 590.87 Million USD | 57.528% |
| Vicarious Surgical Inc. | 80.66 Million USD | -211.109% |
| Smith & Nephew plc | 3.46 Billion USD | 92.761% |
| Sonendo, Inc. | 68.46 Million USD | -266.551% |
| STERIS plc | 1.4 Billion USD | 82.079% |
| Stryker Corporation | 9.2 Billion USD | 97.275% |
| Vapotherm, Inc. | 66.02 Million USD | -280.097% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 92.339% |